Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84+0.01 (+0.97%)
Close on Nov 17, 2026Market cap $13.95MP/E –Yield –
Marker Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Marker Therapeutics's price to sales ratio was 4.8× on Jul 31, 2026, against 2.8× a year earlier. Over the last 4 years it ranged from 1.7× to 407.3×, with a median of 6.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 4.8× | −0.5 |
| 2025 | Dec 31, 2025 | 5.3× | +0.2 |
| 2024 | Dec 31, 2024 | 5.1× | −10.9 |
| 2023 | Dec 29, 2023 | 16.1× | −243.5 |
| 2021 | Apr 30, 2021 | 259.6× | −147.7 |
| 2020 | Mar 31, 2020 | 407.3× | +253.8 |
| 2018 | Apr 30, 2018 | 153.4× | – |
See a number that looks wrong?